Register
AML-ALL EU Focus 2023
International Knowledge & Clinical Practice Conference

The Bloomsbury Hotel 16-22 Great Russell St, London, UK

27-28 October 2023

Register here

Co-chair

Charlie Craddock, MD

Queen Elizabeth Hospital,
Birmingham, UK

Bio

Co-chair

Naval Daver, MD

MD Anderson Cancer Center,
Houston, Texas, USA

Bio

Co-chair

Cristina Papayannidis, MD

Universita di Bologna Italy

Bio

Co-chair

Elias Jabbour, MD

MD Anderson Cancer Center,
Houston, Texas, USA

Bio

Dear Colleagues and Friends,

It is our great pleasure to announce the multinational congress AML-ALL EU Focus 2023 will take place in The Bloomsbury Hotel, London UK scheduled for 27-28 October 2023

The theme of the meeting, International Knowledge & Clinical Practice in 2023, reflects the collaboration to advance the research and treatment of patients with AML and ALL globally.

The meeting will provide participants with a unique opportunity for sharing knowledge, skills and experiences. In addition, this activity will provide a platform for networking with many of the world’s leading experts, focusing on reviewing and assessing best practices and state-of-the-art treatments in AML and ALL.

The meeting program will include presentations, round-table discussions, debates with audience participation, oral abstracts, poster sessions, and a number of informal social gatherings. 

All meeting content will be made available online for 12 months and distributed to 12,000+ HCPS!
AGENDA

It is our pleasure to invite you to participate in this one-of-a-kind event.

If you need additional information please contact us at:

office@md-education.com

MD Education Ltd
4/4a Bloomsbury Square,
London, WC1A 2RP

MD Education USA LLC
4600 140th Avenue North, Suite 180,
Clearwater, Florida 33762

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK

Charles Craddock is Academic Director of the Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK, and Professor of Haemato-oncology, at the University of Birmingham. He trained in haematology at the Hammersmith Hospital, London, the Institute of Molecular Medicine at the University of Oxford and the University of Washington, Seattle, USA.

Professor Craddock is a recent President of the British Society of Blood and Marrow Transplantation and Chair of the UK Stem Cell Strategic Oversight Committee.

Naval Daver, MD

MD Anderson Cancer Center, Houston, Texas, USA

Dr Naval Daver is an associate professor and director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center (MDACC) in Houston, TX.

He is a clinical investigator with a focus on molecular and immune therapies in acute myeloid leukemia (AML) and myeloid disease, and is principal investigator on more than 25 ongoing institutional, national, and international clinical trials in these diseases, including multiple registration and label enabling trials. 

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, Texas, USA

Dr. Jabbour joined the MD Anderson Cancer Center faculty in 2007 and is currently a Professor of Medicine in the Department of Leukemia. He is actively involved in developmental therapeutics research in leukemia. Over the past 5 years he has assisted in developing chemotherapeutic and biologic agents in leukemias and contributed to the development of others.

He was also actively associated with frontline studies of nilotinib and dasatinib which resulted in FDA approval of these agents for frontline CML therapy in 2010.

Please select an option:

Industry
Healthcare Professional